We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.2%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$82.1B
AUM Growth
+$7.21B
(+9.6%)
Cap. Flow
+$2.14B
Cap. Flow
% of AUM
2.6%
Top 10 Holdings %
Top 10 Hldgs %
34.14%
Holding
3,101
New
616
Increased
843
Reduced
896
Closed
659
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$700M |
| 2 |
Meta Platforms (Facebook)
META
|
+$651M |
| 3 |
Flutter Entertainment
FLUT
|
+$606M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$464M |
| 5 |
Accenture
ACN
|
+$402M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$495M |
| 2 |
Spotify
SPOT
|
+$377M |
| 3 |
Humana
HUM
|
+$350M |
| 4 |
Goldman Sachs
GS
|
+$324M |
| 5 |
Merck
MRK
|
+$307M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.11% |
| 2 | Consumer Discretionary | 14.61% |
| 3 | Healthcare | 12.89% |
| 4 | Industrials | 6.78% |
| 5 | Financials | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Liberty Live Group Series A
LLYVA
$9.09B
| $775K | ﹤0.01% |
15,644
-5,456
| -26% | -$213K |
|
|
OPI
1727
DELISTED
Office Properties Income Trust
OPI
| $772K | ﹤0.01% |
354,035
+275,080
| +348% | +$624K |
|
|
ASBPW
1728
CALL
Aspire Biopharma Warrant
ASBPW
$579K
| $770K | ﹤0.01% |
62,081
| – | – |
|
1729
Immunic
IMUX
$188M
| $769K | ﹤0.01% |
46,629
+42,667
| +1,077% | +$607K |
|
1730
BioAtla
BCAB
$5.64M
| $768K | ﹤0.01% |
+8,730
| New | +$732K |
|
|
SNCR
1731
DELISTED
Synchronoss Technologies
SNCR
| $768K | ﹤0.01% |
+51,615
| New | +$604K |
|
1732
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.1B
| $767K | ﹤0.01% |
+18,589
| New | +$713K |
|
1733
Ranpak Holdings
PACK
$572M
| $767K | ﹤0.01% |
117,494
-133,754
| -53% | -$921K |
|
1734
Community Health Systems
CYH
$383M
| $766K | ﹤0.01% |
126,264
-816,039
| -87% | -$4M |
|
1735
Ocular Therapeutix
OCUL
$1.89B
| $763K | ﹤0.01% |
87,743
-341,849
| -80% | -$2.82M |
|
1736
UNIFI
UFI
$121M
| $763K | ﹤0.01% |
103,974
+23,802
| +30% | +$150K |
|
1737
Fluor
FLR
$7.22B
| $752K | ﹤0.01% |
+15,769
| New | +$744K |
|
1738
Fluence Energy
FLNC
$1.79B
| $752K | ﹤0.01% |
33,100
-81,000
| -71% | -$1.46M |
|
1739
Arcosa
ACA
$7.14B
| $747K | ﹤0.01% |
+7,882
| New | +$688K |
|
1740
Pan American Silver
PAAS
$18.6B
| $746K | ﹤0.01% |
35,766
+18,366
| +106% | +$387K |
|
1741
Prelude Therapeutics
PRLD
$310M
| $743K | ﹤0.01% |
+359,137
| New | +$1.66M |
|
1742
Jacobs Solutions
J
$16B
| $743K | ﹤0.01% |
5,735
+3,578
| +166% | +$431K |
|
1743
Silicon Laboratories
SLAB
$7.17B
| $740K | ﹤0.01% |
6,402
-22,269
| -78% | -$2.49M |
|
1744
First Trust NASDAQ Cybersecurity ETF
CIBR
$14B
| $737K | ﹤0.01% |
12,447
+8,395
| +207% | +$479K |
|
1745
Fulgent Genetics
FLGT
$556M
| $734K | ﹤0.01% |
+33,777
| New | +$755K |
|
1746
Medallion Financial
MFIN
$226M
| $734K | ﹤0.01% |
90,145
-47,966
| -35% | -$381K |
|
1747
Sagimet Biosciences
SGMT
$460M
| $730K | ﹤0.01% |
+263,541
| New | +$812K |
|
1748
PUT
Intel
INTC
$462B
| $730K | ﹤0.01% |
31,100
+31,000
| +31,000% | +$774K |
|
|
OPTU
1749
Optimum Communications Inc
OPTU
$298M
| $729K | ﹤0.01% |
296,390
+35,790
| +14% | +$69.1K |
|
1750
MBIA
MBI
$282M
| $729K | ﹤0.01% |
+204,138
| New | +$843K |
|
Similar funds
Marshall Wace's Q3 2024 Portfolio in Review
As of Q3 2024, Marshall Wace held 3,101 positions worth $82.1B, up 9.6% from $74.9B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Marshall Wace's Q3 2024 filing shows 616 new, 843 increased, 896 reduced and 659 closed positions. Its largest new stake was Texas Instruments: 1,008,812 shares worth $208M. The largest sale was Costco, an estimated $495M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Marshall Wace's largest Q3 2024 buy was Texas Instruments: 1,008,812 shares worth $208M.
- Marshall Wace added most to Tesla in Q3 2024, an estimated $700M increase.
- Marshall Wace's biggest Q3 2024 reduction was Costco, cutting an estimated $495M.
- Marshall Wace fully exited Shopify in Q3 2024, selling an estimated $209M.
- Marshall Wace's ten largest holdings make up 34% of its $82.1B portfolio in Q3 2024.
- Marshall Wace opened 616 new positions and closed 659 in Q3 2024.
- Marshall Wace's portfolio value rose 9.6% quarter-over-quarter to $82.1B.
Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.